Management of pulmonary hypertension in special conditions
European Respiratory Journal,
Journal Year:
2024,
Volume and Issue:
64(4), P. 2401180 - 2401180
Published: Aug. 29, 2024
Care
of
pulmonary
hypertension
(PH)
patients
in
special
situations
requires
insightful
knowledge
the
pathophysiology
cardiopulmonary
system
and
close
interaction
with
different
specialists,
depending
on
situation.
The
role
this
task
force
was
to
gather
about
five
conditions
that
PH
may
be
faced
with.
These
are
1)
perioperative
care;
2)
management
pregnancy;
3)
medication
adherence;
4)
palliative
5)
influence
climate
PH.
Many
these
aspects
have
not
been
covered
by
previous
World
Symposia
Pulmonary
Hypertension.
All
above
highly
affected
psychological,
geographical
socioeconomic
factors,
share
need
for
adequate
healthcare
provision.
identified
significant
gaps
information
research
areas.
current
recommendations
based
detailed
literature
search
expert
opinion.
calls
further
studies
better
understand
address
circumstances
encounter.
Language: Английский
Burden of Pulmonary Arterial Hypertension in China from 1990 to 2021, with Projections to 2050: An Analysis of Data from the Global Burden of Disease Study 2021
Shuoshuo Wei,
No information about this author
Yonghui Han,
No information about this author
Min Liu
No information about this author
et al.
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 31, 2025
Abstract
Background
Pulmonary
arterial
hypertension
(PAH)
is
a
severe
condition
with
high
morbidity
and
mortality,
yet
its
epidemiology
in
China
remains
poorly
understood.
This
study
aims
to
assess
the
burden
of
PAH
from
1990
2021
project
trends
2050,
providing
insights
for
effective
management
prevention
strategies.
Method
Data
Global
Burden
Disease
(GBD)
Study
were
analyzed,
focusing
exclusively
on
PAH.
Key
metrics
included
incidence,
prevalence,
disability-adjusted
life
years
(DALYs),
along
their
corresponding
age-standardized
rates
(ASRs).
Average
annual
percent
changes
(AAPCs)
calculated
using
joinpoint
regression
analysis,
Bayesian
age-period-cohort
model
was
employed
through
2050.
Results
In
2021,
there
41,135
estimated
prevalent
cases
(95%
UI:
32,838.91
51,357.25)
China,
an
prevalence
rate
(ASPR)
2.24
per
100,000.
Females
accounted
approximately
58%
cases.
caused
7,318
deaths
4,835.72
9,075.75;
3,683
males,
3,635
females),
death
(ASDR)
0.42
From
ASPR
increased
slightly
2.07
1.68
2.54)
1.81
2.75),
while
ASDR
decreased
0.61
0.46
0.83)
0.28
0.51).
Projections
suggest
declining
both
ASDR,
although
overall
expected
rise
over
next
30
years.
Conclusion
imposes
significant
disease
particularly
among
women
older
adults.
These
findings
highlight
urgent
need
enhance
diagnostic
capabilities
develop
improved
treatment
strategies
address
this
challenging
Chinese
population.
Language: Английский
Association between hydrocarbon exposure and risk of stroke: a systematic literature review
BMC Neurology,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: Feb. 21, 2025
Abstract
Background
Hydrocarbon
exposure,
including
polycyclic
aromatic
hydrocarbons
(PAHs)
and
volatile
organic
compounds
(VOCs),
is
increasingly
linked
to
vascular
dysfunction
stroke,
a
leading
cause
of
morbidity
mortality
globally.
Common
in
occupational
environmental
contexts,
induce
oxidative
stress,
systemic
inflammation,
endothelial
dysfunction,
disrupting
health.
This
systematic
review
examines
the
association
between
hydrocarbon
exposure
emphasizing
specific
metabolites
their
cerebrovascular
effects.
Methods
A
comprehensive
search
across
PubMed,
Embase,
Web
Science
was
conducted
through
December
10
2024,
identifying
observational
studies
exploring
stroke
risk.
Studies
meeting
predefined
inclusion
criteria,
excluding
those
with
major
methodological
flaws,
were
synthesized
narratively.
Variations
types,
population
demographics,
outcomes
considered.
Results
Six
studies,
five
cross-sectional
one
retrospective
cohort,
sample
sizes
ranging
from
5,537
283,666
participants,
demonstrated
significant
associations
Key
findings
revealed
strong
for
like
1-hydroxynaphthalene
(OR:
1.89;
95%
CI:
1.62–2.20)
2-hydroxyfluorene
1.94;
1.66–2.26).
However,
variability
noted,
attributed
differences
study
design,
levels,
populations
studied.
Conclusion
highlights
complex
relationship
risk,
some
indicating
others
reporting
inconsistencies.
Standardized,
large-scale
research
essential
clarify
this
relationship,
identify
high-risk
populations,
guide
public
health
strategies
mitigate
prevent
stroke.
Clinical
trial
number
Not
applicable.
Language: Английский
Infection and pulmonary vascular diseases consortium: United against a global health challenge
Pulmonary Circulation,
Journal Year:
2024,
Volume and Issue:
14(4)
Published: Oct. 1, 2024
Abstract
Leveraging
the
potential
of
virtual
platforms
in
post‐COVID‐19
era,
Infection
and
Pulmonary
Vascular
Diseases
Consortium
(iPVDc),
with
support
Research
Institute
(PVRI),
launched
a
globally
accessible
educational
program
to
highlight
top‐notch
research
on
inflammation
infectious
diseases
affecting
lung
vasculature.
This
innovative
series
has
already
successfully
brought
together
distinguished
investigators
across
five
continents
–
Asia,
Europe,
South
North
America,
Africa.
Moreover,
these
open
global
forums
have
contributed
comprehensive
understanding
complex
interplay
among
immunology,
inflammation,
infection,
cardiopulmonary
health,
especially
concerning
pulmonary
hypertension
related
disorders.
These
enlightening
discussions
not
only
heightened
awareness
about
impact
various
pathogenic
microorganisms,
including
fungi,
parasites,
viruses,
onset
development
vascular
but
also
cast
spotlight
co‐infections
neglected
illnesses
like
schistosomiasis
‐
disease
that
continues
impose
heavy
socioeconomic
burden
numerous
regions
worldwide.
Thus,
overall
goal
this
review
article
is
present
most
recent
breakthroughs
from
PVDs
as
well
bring
light
scientific
insights
2023
iPVDc/PVRI
symposium
series,
shaping
our
crucial
health
issues
more
than
ever
interconnected
world.
Language: Английский
Assessing the causality between pulmonary arterial hypertension and cancer: insights from Mendelian randomization
Discover Oncology,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Dec. 21, 2024
Previous
clinical
studies
have
suggested
an
increased
risk
of
tumor
development
in
patients
with
pulmonary
arterial
hypertension
(PAH).
However,
it
remains
unclear
whether
there
is
a
causal
relationship
between
PAH
and
occurrence.
This
study
investigates
the
link
cancer
from
genetic
perspective
using
Mendelian
randomization
(MR).
Genome-wide
association
(GWAS)
summary
data
for
various
common
types
were
obtained
GWAS
Catalog.
Single
nucleotide
polymorphisms
(SNPs)
significantly
associated
at
genome-wide
significance
threshold
(P
<
1
×
10−6)
selected
as
instrumental
variables
(IVs).
Inverse-variance
weighted
(IVW)
was
used
primary
method
MR
analysis,
sensitivity
analyses
including
tests
heterogeneity
horizontal
pleiotropy.
The
results
IVW
analysis
indicate
that
genetically
proxied
liver
[odd
ratio
(OR)
1.11,
95%
confidence
interval
(CI)
1.01–1.22,
P
=
0.025),
while
showing
no
significant
other
tumors
(thyroid
cancer:
OR
0.95,
CI
0.86–1.06,
0.360;
lung
0.90–1.01,
0.129;
gastric
0.97,
0.93–1.02,
0.243;
colorectal
1.01,
0.98–1.05,
0.412).
Except
examining
effect
on
0.049),
remaining
displayed
>
0.05).
Additionally,
MR-Egger
intercept
test
did
not
find
evidence
pleiotropy
highlights
may
serve
potential
factor
this
cancer.
Future
research
should
aim
to
elucidate
biological
mechanisms
play
explore
early
interventions
could
mitigate
vulnerable
population.
Language: Английский